Oramed Announces Oravax’s Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial

  • by

NEW YORK, October 29, 2021 – Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that its majority-owned subsidiary, Oravax Medical Inc. (www.ora-vax.com), has received clearance from the South African Health Products Regulatory Authority to commence… Read More »Oramed Announces Oravax’s Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial

Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial

  • by

Oravax’s virus-like particle (VLP) vaccine being tested against COVID-19 variants including Delta  Oravax signs licensing deal for VLP injectable vaccine technology with Premas Biotech for commercialization in India  NEW YORK, July 21, 2021 – Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development… Read More »Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial

Gulf News: An oral COVID vaccine is nearly ready, will it help end the pandemic?

  • by

Washington/Dubai: Imagine a COVID-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes. Israeli pharmaceutical Oramed is attempting to accomplish just that, and is poised to start its first clinical trial in early August, CEO Nadav… Read More »Gulf News: An oral COVID vaccine is nearly ready, will it help end the pandemic?

Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines

  • by

The Oral Vaccine Successfully Produced Antibodies in a Preclinical Study After a Single Dose Good candidate for protection against COVID variants due to triple antigen targeting Implications for potential ease of widescale distribution and administration anytime, anywhere for oral COVID-19 vaccine Efficacy following a single oral dose administration… Read More »Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines